Guidelines International Network | Guidelines International Network (GIN)

Safe Administration of Chemotherapy: Methods and Development

MeSH Terms: Oncology Nursing (H02.478.676.605); Neoplasms (C04); Antineoplastic Protocols (E02.183.750); Antineoplastic Agents (D27.505.954.248); Medication Systems (N04.452.528)
Guideline Contact: Cindy Walker-Dilks ([email protected])
Publication Scope: treatment
Countries of Application: Canada
Guideline Publication Status: Published
Languages: English
Authors: McMaster University (CA)
Publication Year: 2012

MeSH Terms: Antineoplastic Agents (D27.505.954.248); Outpatients (M01.643.630); Ambulatory Care (E02.760.106)
Guideline Contact: Cindy Walker-Dilks ([email protected])
Publication Scope: treatment
Countries of Application: Canada
Guideline Publication Status: Published
Languages: English
Authors: McMaster University (CA)
Publication Year: 2012

MeSH Terms: Practice Guideline (V02.515.500); Guideline (V02.515); Practice Guidelines as Topic (N04.761.700.350.650)
Guideline Contact: Cindy Walker-Dilks ([email protected])
Publication Scope: treatment
Countries of Application: Canada
Guideline Publication Status: Published
Languages: English
Authors: McMaster University (CA)
Publication Year: 2014

MeSH Terms: occupational exposure, health personnal, oncologic nursing, oncology service, hospital, pharmacy, pharmacy service, antineoplastic agents, occupational diseases, abnormalities, drug-induced, environmental exposure, carcinogens, teratogens, drug toxicity, hazardous substances, phaseal, closed-system, drug compounding, choclave, Spiros, onguard, baxa, Tevadaptor, environmental monitoring, pregnancy, neoplasms, nurses, health care worker, pharmacist, pharmacy technician, adverse outcome, cancer chemotherapy, chemotherapy, biological monitoring
Guideline Contact: Nadia Coakley; [email protected]
Keywords: occupational exposure, health personnal, oncologic nursing, antineoplastic agents, occupational diseases
Date for Review: In Program in Evidence-Based Care (PEBC), Ontario Health (Cancer Care Ontario), we have an annual review process for each guideline after it is completed. Guidelines are reviewed every fall after they are older than 1 year.
Publication Date: 2022-09-26
Date of Last Evidence Search: 2022-08-27
Methods Applied: Systematic review-based, Externally reviewed, Evidence quality assessment, Patient/survivors/caregivers participation
Publication Scope: Guidelines
Countries of Application: Canada
Guideline Publication Status: Published
Languages: English
Authors: PEBC (Program in evidenced-based care)
Publication Year: 2022

MeSH Terms: Personnel Staffing and Scheduling (N04.452.677.650); Hospitals; Maternity (N02.278.421.556.366)
Publication Scope: management
Countries of Application: United Kingdom
Guideline Publication Status: Published
Languages: English
Authors: NICE (UK)
Publication Year: 2015

MeSH Terms: Mental Disorders (F03); Social Support (I01.880.656.600
Publication Scope: assessment; implementation; management; monitoring; Social Considerations
Countries of Application: United Kingdom
Guideline Publication Status: Published
Languages: English
Authors: NICE (UK)
Publication Year: 2021

MeSH Terms: Sick Leave (N01.824.417.700.662); Sick Leave (N04.452.677.800.662)
Guideline Contact: Raija Sipilä ([email protected])
English Title Translation: Assessment of sick leave
Expected Publication Date: 31/08/2019
Publication Scope: management
Countries of Application: Finland
Guideline Publication Status: Published
Languages: Finnish
Authors: CC (FI)
Publication Year: 2019

MeSH Terms: Uterine Diseases (C13.371.852); Neoplasms by Histologic Type (C04.557)
English Title Translation: Uterine sarcoma and the Carcinosarcoom
Publication Scope: assessment; management; rehabilitation
Countries of Application: Netherlands
Guideline Publication Status: Published
Languages: Dutch
Authors: IKNL (NL)
Publication Year: 2010